Neuromyelitis Optica Spectrum Disorders in North Indian Population: Experience from a Tertiary Care Center

被引:3
|
作者
Sachdeva, Julie [1 ]
Goyal, Manoj K. [1 ]
Singh, Ramandeep [2 ]
Kapila, Aastha T. [1 ]
Singh, Paramjeet [3 ]
Saikia, Biman [4 ]
Lal, Vivek [1 ]
机构
[1] PGIMER, Dept Neurol, Chandigarh, India
[2] PGIMER, Dept Ophthalmol, Chandigarh, India
[3] PGIMER, Dept Radiodiag & Intervent Radiol, Chandigarh, India
[4] PGIMER, Dept Immunopathol, Chandigarh, India
关键词
Neuromyelitis optica; North Indian; NMOSD; AQUAPORIN; 4; AQP4; MOG;
D O I
10.4103/0028-3886.355118
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: To understand neuromyelitis optica spectrum disorders (NMOSDs) better we need to study them in different populations. This prospective study was conducted to characterize clinical, serological, radiological, and therapeutic profile of NMOSDs in a North Indian population. Materials and Methods: This study included 81 patients with NMOSDs. All patients underwent detailed history and examinations and were followed at 3 monthly intervals. They were evaluated using standard investigations including gadolinium-enhanced magnetic resonance imaging (MRI) of the brain and spine with thin section optic nerve cuts and treated as per the standard guidelines. Data were recorded meticulously. Results: The mean age was 33.7 +/- 13.4 years. The mean age at disease onset was 31.2 +/- 13.5 years. Female-to-male ratio was 1.9:1. About 32.1% of patients presented with optic neuritis (ON), 56.8% with transverse myelitis (TM), and 11.1% with both ON and TM. The mean time from disease onset to diagnosis was 16.17 +/- 23.09 months. Muscle atrophy, Lhermitte symptom, and tonic spasms were common. Foster-Kennedy syndrome-like presentation was seen in 8.6%. NMO antibodies were positive in 41 patients. MRI revealed involvement of <4 vertebral segments in 16.4% of patients with TM. Patients were managed as per standard guidelines. The mean follow-up duration was 15.3 +/- 6 months. Approximately 88.9% had good functional outcome. Conclusion: NMOSDs are a common cause of demyelinating illnesses in Northern India. The response to treatment is excellent and most patients recover without residual disability.
引用
收藏
页码:1500 / 1505
页数:6
相关论文
共 50 条
  • [41] Neuromyelitis optica spectrum disorders with and without connective tissue disorders
    Chun-Sheng Yang
    Qiu Xia Zhang
    Sheng Hui Chang
    Lin Jie Zhang
    Li Min Li
    Yuan Qi
    Jing Wang
    Zhi Hua Sun
    Nannan Zhangning
    Li Yang
    Fu-Dong Shi
    BMC Neurology, 18
  • [42] Neuromyelitis optica spectrum disorders without and with autoimmune diseases
    Bingjun Zhang
    Yi Zhong
    Yanqiang Wang
    Yongqiang Dai
    Wei Qiu
    Lei Zhang
    Haiyan Li
    Zhengqi Lu
    BMC Neurology, 14
  • [43] Neuromyelitis Optica Spectrum Disorders in Africa A Systematic Review
    Musubire, Abdu Kisekka
    Derdelinckx, Judith
    Reynders, Tatjana
    Meya, David B.
    Bohjanen, Paul R.
    Cras, Patrick
    Willekens, Barbara
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (06):
  • [44] Prof. Ren ZHANG's experience in acupuncture for neuromyelitis optica spectrum disorders
    Yang, Wei-jie
    Qian, Jia-hua
    Zhang, Ren
    Xu, Hong
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2022, 32 (02) : 178 - 183
  • [45] Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
    Benjamin Berger
    Tilman Hottenrott
    Sebastian Rauer
    Oliver Stich
    BMC Neurology, 17
  • [46] Visual impairment in neuromyelitis optica spectrum disorders (NMOSD)
    Wu, Yan
    Zhong, Lianmei
    Geng, Jia
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 97 : 66 - 70
  • [47] Recent advances in the treatment of neuromyelitis optica spectrum disorders
    Romeo, Andrew R.
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 233 - 239
  • [48] Neuromyelitis optica spectrum disorders without and with autoimmune diseases
    Zhang, Bingjun
    Zhong, Yi
    Wang, Yanqiang
    Dai, Yongqiang
    Qiu, Wei
    Zhang, Lei
    Li, Haiyan
    Lu, Zhengqi
    BMC NEUROLOGY, 2014, 14
  • [49] Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
    Held, Friederike
    Klein, Ana-Katharina
    Berthele, Achim
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 87 - 101
  • [50] Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study
    Martins, Cecilia
    Moura, Joao
    Figueiroa, Sonia
    Garrido, Cristina
    Martins, Joana
    Samoes, Raquel
    Guimaraes, Joana
    Melo, Claudia
    Sousa, Raquel
    Palavra, Filipe
    Ferreira, Joao
    da Silva, Ana Martins
    Sa, Mario Jose
    Santos, Ernestina
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59